Fei-Fei Ge

Fei-Fei Ge

Auto-generated profile, based on publicly available information

Fei-Fei Ge

Shanghai Municipal Center For Animal Disease Diagnosis, Shanghai Animal Disease Control Center, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
FGFei-Fei Ge
Fei-Fei Ge
DYDe-Quan Yang
De-Quan Yang
XLXin Li
Xin Li
HJHou-Bin Ju
Hou-Bin Ju
HSHai-Xiao Shen
Hai-Xiao Shen
JWjian wang
jian wang
In February and December of 2019, two large-scale outbreaks of diarrhea were observed in the same swine farm with 3,000 sows in Shanghai, China. We successfully isolated two porcine epidemic diarrhea virus (PEDV) isolates (strains shxx1902 and shxx1912 in February and December, respectively) from clinical samples in this farm using suspension Vero cells. A third PEDV strain (SH1302) tested positive in another farm of Shanghai, China, in 2013 and was also isolated using suspension Vero cells.

6 August 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
FGFei-Fei Ge
Fei-Fei Ge
LSLi-Pin Shen
Li-Pin Shen
DYDe-Quan Yang
De-Quan Yang
XYXian-Cao Yang
Xian-Cao Yang
XLXin Li
Xin Li
SHShixin Huang
Shixin Huang
In 2016, a distinct branch of H3N2 canine influenza virus (CIV) emerged, which has mutations related to mammalian adaptation and has replaced previously prevalent strains. This branch poses a risk of zoonotic infection. To prevent and control H3N2 CIV, an H3N2 virus-like particle (VLP) vaccine based on the insect cell baculovirus expression system has been developed in the study. The H3N2 VLP vaccine induced high titers of hemagglutination inhibition (HI) antibodies in nasal and muscular immunized beagle dogs. Meanwhile, the VLP vaccine provided effective protection against homologous virus challenge comparable to inactivated H3N2 canine influenza virus. In addition, the intranasal H3N2 VLP vaccine induced significantly higher Th1, Th2, and Th17 immune responses, respectively (p,0.05). Importantly, intramuscular injection of VLP and inactivated H3N2 virus has complete protective effects against homologous H3N2 virus attacks. Nasal immunization with H3N2 VLP can partially protect beagles from H3N2 influenza. IMPORTANCE: A new antigenically and genetically distinct canine influenza virus (CIV) H3N2 clade possessing mutations associated with mammalian adaptation emerged in 2016 and substituted previously circulating strains. This clade poses a risk for zoonotic infection. In our study, intramuscular injection of the H3N2 virus-like particle (VLP) vaccine and inactivated H3N2 CIV confer completely sterilizing protection against homologous H3N2 canine influenza virus challenge. Our results provide further support for the possibility of developing VLP vaccines that can reliably induce immunity in animal species.